Lateral Flow Immunoassay Validated for Detection of Cryptococcal Antigen
|
By LabMedica International staff writers Posted on 23 Feb 2015 |
|
Image: The CrAg lateral flow assay to detect cryptococcal antigens (Photo courtesy of Immuno-Mycologics).
Cryptococcosis is an important and potentially lethal opportunistic infection in immunocompromised patients, especially in human immunodeficiency virus (HIV) infected and organ transplant patients.
The incidence of the infection in non-HIV immunocompromised patients caused by Cryptococcus neoformans and in immunocompetent patients caused by C. gattii has increased in developed countries.
Medical microbiologists at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) compared a lateral flow immunoassay (LFA) to a currently used enzyme immunoassay for detection of cryptococcal antigen in 396 sera and 651 cerebrospinal fluid specimens. The cryptococcal antigen detection was performed in retrospective and prospective sera and CSF specimens collected from March 2010 to August 2012 in patients suspected of cryptococcal infection from the Johns Hopkins Hospital, an academic tertiary care hospital.
The newly developed CrAg lateral flow immunoassay (LFA) (Immuno-Mycologics [IMMY]; Norman, OK, USA) offers a rapid and easy alternative detection platform. The LFA assay detects glucuronoxylomannan (GXM), the major polysaccharide component of the cryptococcal capsule. It is a dipstick sandwich immunochromatographic assay that captures the GXM by gold-conjugated anti-Cryptococcus monoclonal antibodies incorporated on the dipstick membrane. This test was compared with an enzyme immunoassay (EIA) from Meridian Premier (Meridian Biosciences; Cincinnati, OH, USA).
The scientists found 97% concordance between the two assays. The LFA assay detected an additional 22 positives. Overall, the LFA had sensitivity of 100% and specificity of 99.6% for the diagnosis of cryptococcosis. Although reading the LFA result can be subjective, they found that the visible lines suggestive of positive results are usually easy to determine. Easy readability combined with additional advantages of rapid turn-around time of 10-minutes ease of performance, requiring little technical expertise, and limited cost make the LFA an attractive tool for routine laboratory use.
The authors concluded that the IMMY LFA showed better sensitivity in detecting C. neoformans antigen in serum and CSF specimens compared to an EIA method in current use. Because of the enhanced sensitivity, users must be aware of the possibility of false positive results in patients with low clinical suspicion of cryptococcal infection. The LFA is rapid, accurate, easy to perform, and cost-effective, and thus it is attractive for implementation by clinical laboratories for routine patient care testing. The study was published on January 31, 2015, in the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Johns Hopkins University School of Medicine
Immuno-Mycologics
Meridian Biosciences
 (3) (1).png)
The incidence of the infection in non-HIV immunocompromised patients caused by Cryptococcus neoformans and in immunocompetent patients caused by C. gattii has increased in developed countries.
Medical microbiologists at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) compared a lateral flow immunoassay (LFA) to a currently used enzyme immunoassay for detection of cryptococcal antigen in 396 sera and 651 cerebrospinal fluid specimens. The cryptococcal antigen detection was performed in retrospective and prospective sera and CSF specimens collected from March 2010 to August 2012 in patients suspected of cryptococcal infection from the Johns Hopkins Hospital, an academic tertiary care hospital.
The newly developed CrAg lateral flow immunoassay (LFA) (Immuno-Mycologics [IMMY]; Norman, OK, USA) offers a rapid and easy alternative detection platform. The LFA assay detects glucuronoxylomannan (GXM), the major polysaccharide component of the cryptococcal capsule. It is a dipstick sandwich immunochromatographic assay that captures the GXM by gold-conjugated anti-Cryptococcus monoclonal antibodies incorporated on the dipstick membrane. This test was compared with an enzyme immunoassay (EIA) from Meridian Premier (Meridian Biosciences; Cincinnati, OH, USA).
The scientists found 97% concordance between the two assays. The LFA assay detected an additional 22 positives. Overall, the LFA had sensitivity of 100% and specificity of 99.6% for the diagnosis of cryptococcosis. Although reading the LFA result can be subjective, they found that the visible lines suggestive of positive results are usually easy to determine. Easy readability combined with additional advantages of rapid turn-around time of 10-minutes ease of performance, requiring little technical expertise, and limited cost make the LFA an attractive tool for routine laboratory use.
The authors concluded that the IMMY LFA showed better sensitivity in detecting C. neoformans antigen in serum and CSF specimens compared to an EIA method in current use. Because of the enhanced sensitivity, users must be aware of the possibility of false positive results in patients with low clinical suspicion of cryptococcal infection. The LFA is rapid, accurate, easy to perform, and cost-effective, and thus it is attractive for implementation by clinical laboratories for routine patient care testing. The study was published on January 31, 2015, in the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Johns Hopkins University School of Medicine
Immuno-Mycologics
Meridian Biosciences
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Pipette
Accumax Smart Series
Laboratory Software
ArtelWare
Latest Microbiology News
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
- Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read more
Molecular Diagnostics
view channel
New Diagnostic Method Detects Pneumonia at POC in Low-Resource Settings
Pneumonia continues to be one of the leading causes of death in low- and middle-income countries, where limited access to advanced laboratory infrastructure hampers early and accurate diagnosis.... Read more
Blood Immune Cell Analysis Detects Parkinson’s Before Symptoms Appear
Early diagnosis of Parkinson’s disease remains one of the greatest challenges in neurology. The condition, which affects nearly 12 million people globally, is typically identified only after significant... Read more
Hematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Immunology
view channel
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read more
Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
Modern cancer immunotherapies rely on the ability of CD8⁺ T cells to rapidly multiply within tumors, generating the immune force needed to eliminate cancer cells. However, the biological triggers behind... Read more
Pathology
view channel
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read more
Technology
view channel
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read more
Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
Blood tests remain a cornerstone of medical diagnostics, but traditional imaging and analysis methods can be slow, costly, and reliant on dyes or contrast agents. Now, scientists have developed a real-time,... Read more
Industry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more
